Old Web
English
Sign In
Acemap
>
Paper
>
PDB9 IMPACT OF FDA SAFETY WARNINGS ON SUBSEQUENT DIABETES CARE FOR USERS OF ROSIGLITAZONE
PDB9 IMPACT OF FDA SAFETY WARNINGS ON SUBSEQUENT DIABETES CARE FOR USERS OF ROSIGLITAZONE
2009
D Huse
R Bizier
Keywords:
Medical emergency
Medicine
Rosiglitazone
Diabetes mellitus
Intensive care medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]